AYA Survivorship

  • Victoria GrandageEmail author
  • Susan Mehta
  • Rachael Windsor


Since the 1970s, the incidence of cancer in 15–24 year olds in the UK has increased by 55% with 2,405 new cases each year from 2012 to 2014. Recent data indicates that more than 80% of teenagers and young adults diagnosed with cancer will now survive for longer than 5 years [1]. Overall survival has almost doubled in the last four decades, although this ranges from almost 100% for thyroid carcinomas to 55% for acute myeloid leukaemia or bone sarcoma [2]. Consequently, the majority of adolescent and young adult cancer patients will become long-term survivors. Most will have been treated with combinations of multi-agent chemotherapy, radiotherapy and surgery and may develop health complications that become apparent at the end of treatment or many years later, so-called ‘Late Effects’.


  1. 1.
    O’Hara C, et al. Trends in survival for teenagers and young adults with cancer in the UK. Eur J Cancer. 2015;51(14):2039–48.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
  3. 3.
    Chemaitilly W, Cohen LE. Diagnosis of endocrine disease: endocrine late-effects of childhood cancer and its treatment. Eur J Endocrinol. 2017;176(4):R183–203.CrossRefPubMedGoogle Scholar
  4. 4.
    PDQ Cancer Information Summaries. Late effects of treatment for childhood cancer health professionals version. 2017.Google Scholar
  5. 5.
    O’Sullivan D. Late effects of chemotherapeutic agents on renal function in childhood cancer survivors: a review. Ir J Med Sci. 2017;186(1):49–55.CrossRefPubMedGoogle Scholar
  6. 6.
    Akam-Venkata J, Franco VI, Lipshultz SE. Late cardiotoxicity: issues for childhood cancer survivors. Curr Treat Options Cardiovasc Med. 2016;18(7):47.CrossRefPubMedGoogle Scholar
  7. 7.
    Oeffinger KC, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355:1572–82.CrossRefPubMedGoogle Scholar
  8. 8.
    Hudson MM, et al. High-risk populations identified in Childhood Cancer Survivor Study Investigations: implications for risk based surveillance. JCO. 2009;27(14):2405–14.CrossRefGoogle Scholar
  9. 9.
  10. 10.
    Lethaby CD, et al. A systematic review of time to diagnosis in children and young adults with cancer. Arch Dis Child. 2013;98:349–55.CrossRefPubMedGoogle Scholar
  11. 11.
    Fern L, et al. Why can’t we improve timeliness of cancer diagnosis in children, teenagers and young adults? BMJ. 2013;347:f6493.CrossRefPubMedGoogle Scholar
  12. 12.
    van der Graaf WT, et al. Soft tissue sarcomas in adolescents and young adults: a comparison with their paediatric and adult counterparts. Lancet Oncol. 2017;18(3):e166–75.CrossRefPubMedGoogle Scholar
  13. 13.
    Gaspar N, Fern L. Increasing access to clinical trials and innovative therapy for teenagers and young adults with cancer – a multiple stakeholders and multiple steps process. Prog Tumor Res. 2016;43:38–49.CrossRefPubMedGoogle Scholar
  14. 14.
    Hough R, Rowntree C, Goulden N, Mitchell C, Moorman A, Wade R, Vora A. Efficacy and toxicity of a paediatric protocol on teenagers and young adults with Philadelphia chromosome negative acute lymphoblastic leukaemia: results from UKALL 2003. Br J Haematol. 2016;172(3):439–51.CrossRefPubMedGoogle Scholar
  15. 15.
    Woodward E, Jessop M, Glaser A, Stark D. Late effects in survivors of teenage and young adult cancer: does age matter? Ann Oncol. 2011;22(12):2561–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Hudson MM, et al. High-risk populations identified in Childhood Cancer Survivor Study Investigations: implications for risk based surveillance. J Clin Oncol. 2009;27(14):2405–14.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    MacArthur AC, Spinelli JJ, Rogers PC, et al. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia. Pediatr Blood Cancer. 2007;48(4):453–9.CrossRefPubMedGoogle Scholar
  18. 18.
    Travis LB, Fossa SD, Schonfeld SJ, et al. Second cancers among 40576 testicular cancer patients: focus on long term survivors. J Natl Cancer Inst. 2005;97(18):1354–65.CrossRefPubMedGoogle Scholar
  19. 19.
    Mulrooney DA, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ. 2009;339:b4606.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Swerdlow AJ, et al. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J Natl Cancer Inst. 2007;99(3):206–14.CrossRefPubMedGoogle Scholar
  21. 21.
    Aleman BM, et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood. 2007;109(5):1878–86.CrossRefPubMedGoogle Scholar
  22. 22.
    Reinders JG, et al. Ischemic heart disease after mantlefield irradiation for Hodgkin’s disease in long-term follow-up. Radiother Oncol. 1999;51(1):35–42.CrossRefPubMedGoogle Scholar
  23. 23.
    van den Belt-Dusebout A, Nuver J, de Wit R, et al. Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol. 2006;24(3):467–75.CrossRefPubMedGoogle Scholar
  24. 24.
    Sklar C, Whitton J, Mertens A, et al. Abnormalities of the thyroid in survivors of Hodgkin’s disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab. 2000;85(9):3227–32.PubMedGoogle Scholar
  25. 25.
    Kadan-Lottick NS, et al. Osteonecrosis in adult survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2008;26(18):3038–45.CrossRefPubMedGoogle Scholar
  26. 26.
    Bright C, Hawkins M, Guha J, Henson K, Winter D, Kelly J, Feltbower R, Hall M, Cutter D, Edgar A, Frobisher C, Reulen R. Risk of cerebrovascular events in 178 962 five-year survivors of cancer diagnosed at 15 to 39 years of age: the TYACSS (Teenage and Young Adult Cancer Survivor Study). Circulation. 2017;135(13):1194–210.CrossRefPubMedGoogle Scholar
  27. 27.
    Tai E, et al. Health status of adolescent and young adult cancer survivors. Cancer. 2012;118:4884–91.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Barnett M, McDonnell G, DeRosa ST, Philip E, Peterson L, Touza K, Jhanwar S, Atkinson T, Ford J. Psychosocial outcomes and interventions among cancer survivors diagnosed during adolescence and young adulthood (AYA): a systematic review. J Cancer Surviv. 2016;10(5):814–31.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Hauken M, Larsen TMB, Holsen I. Meeting reality: young adult cancer survivors’ experiences of reentering everyday life after cancer treatment. Cancer Nurs. 2013;36:E17–26.CrossRefPubMedGoogle Scholar
  30. 30.
    Warner E, Kent E, Trevino K, Parsons H, Zebrack B, Kirchoff A. Social well-being among adolescents and young adults with cancer: a systematic review. Cancer. 2016;122:1029–37.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Smits-Seemann RR, Kaul S, Zamora ER, Wu YP, Kirchhoff AC. Barriers to follow up care among survivors of AYA cancer. J Cancer Surviv. 2017 Feb;11(1):126–32.CrossRefPubMedGoogle Scholar
  32. 32.
    Blum R, Garell D, Hodgman C, Jorissen T, Okinow N, Orr D, Slap G. Transition from child-centred to adult health-care systems for adolescents with chronic conditions. A position paper for the society of adolescent medicine. J Adolesc Health. 1993;14:570–6.CrossRefPubMedGoogle Scholar
  33. 33.
    Mulder R, Van der Paul H, Levitt G, Skinner R, Kremer L, Brown M, Bardi E, Windsor R, Michel G, Frey E. Transition guidelines: an important step in the future care for childhood cancer survivors. A comprehensive definition as groundwork. Eur J Cancer. 2016;54:64–8.CrossRefPubMedGoogle Scholar
  34. 34.
  35. 35.
    Competences. An integrated career and competence framework for nurses working in the field of long-term follow-up and late effects care of children and young people after cancer. Published by RCN and NHS improvement. Publication code 004172. 2011.Google Scholar
  36. 36.
    Models of care to achieve better outcomes for children and young people living with and beyond cancer. March 2011.
  37. 37.
    National Cancer survivorship Initiative – Children and Young People Workstream. 4th Children and Young people National Survivorship Workshop. 2010.Google Scholar
  38. 38.
    McQuillan RF, Toulany A, Kaufman M, Schiff JR. Benefits of a transfer clinic in adolescent and young adult kidney transplant patients. Can J Kidney Health Dis. 2015;2:45.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Royal College of Physicians of Edinburgh. Think transition: developing the essential link between paediatric and adult care. Edinburgh. 2008.
  40. 40.
    Cancer Services for Children and Young People. Quality standard [QS55]. 2014.
  41. 41.
    Casillas J, Syrjala KL, Ganz PA, et al. How confident are young adult cancer survivors in managing their survivorship care? A report from the LIVESTRONG Survivorship Center of Excellence Network. J Cancer Surviv. 2011;5(4):371–81.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Haugnes HS, Oldenburg J, Bremnes RM. Pulmonary and cardiovascular toxicity in long-term testicular cancer survivors. Urol Oncol. 2015;33(9):399–406.CrossRefPubMedGoogle Scholar
  43. 43.
    Bradford NK, Chan RJ. Health promotion and psychological interventions for adolescent and young adult cancer survivors: A systematic literature review. Cancer Treat Rev. 2017;55:57–70.CrossRefPubMedGoogle Scholar
  44. 44.
    Mariotto AB, et al. Long term survivors of childhood cancers in the United States. Cancer Epidemiol Biomarkers Prev. 2009;18:1033–40.CrossRefPubMedGoogle Scholar
  45. 45.
    Mulder R, Kremer L, Hudson M, Bhatia S, Landier W, Levitt G, Constine L, Wallace H, Leeuwen F, Ronckers C, Henderson T, Dwyer M, Skinner R, Oeffinger K. Recommendations for breast cancer surveillance for female survivors of childhood, adolescent and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2013;14(13):e621–9.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Skinner R, Mulder R, Kremer L, Hudson M, Constine L, Bardi E, Boekhout A, et al. Recommendations for gonadotoxicity surveillance in male childhood, adolescent and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. Lancet Oncol. 2017;18(2):e75–90.CrossRefPubMedGoogle Scholar
  47. 47.
    van Dorp W, Mulder R, Kremer L, Hudson M, van den Heuvel-Eibrink M, van den Berg M, Levine J, et al. Recommendations for premature ovarian insufficiency surveillance for female survivors of childhood, adolescent and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. J Clin Oncol. 2016;34(28):3440–50.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Armenian S, Hudson M, Mulder R, Chen M, Constine L, Dwyer M, Nathan P, Tissing W, et al. Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2015;16(3):e123–36.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Cox A, Faithfull S. ‘They’re survivors physically but we want them to survive mentally as well’: health care professionals’ views on providing potential late effect information. Support Care Cancer. 2013;21(9):2491–7.CrossRefPubMedGoogle Scholar
  50. 50.
    Wallace H, Blacklay A, Eiser C, Davies H, Hawkins M, Levitt G, Jenney ME. Late effects committee of the United Kingdom Children’s Cancer Study Group (UKCCSG). Developing strategies for long term follow up of survivors of childhood cancer. BMJ. 2001;323(7307):271–4.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Miedema B, Easley J, Robinson LM. Do current cancer follow-up care practices meet the needs of young adult cancer survivors in Canada? A qualitative inquiry. Curr Oncol. 2013;20(1):14–22.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Kam V, Hendershot E, Anderson L, Marjerrison S. Evaluation of a joint adult and pediatric clinic for cancer survivorship care. Pediatr Blood Cancer. 2017; [Epub ahead of print].
  53. 53.
    Skinner R, Wallace H, Levitt G. Therapy based long term follow up. Practice statement. United Kingdom’s Children’s Cancer Study Group. 2nd edition. 2005.
  54. 54.
    Scottish Intercollegiate Guidelines Network 76. Long term follow up of survivors of childhood cancer Quick Reference Guide. Jan 2004.
  55. 55.
    Late Effects of Treatment for Childhood Cancer – Health Professional Version.
  56. 56.
    Children’s Oncology Group Long Term Follow Up Guidelines version 4.0 2014.
  57. 57.
    Self-management approaches for people with chronic conditions patient education and counselling. NHS England - NHS Five Year Forward View. 48:177–187. October 2014.Google Scholar
  58. 58.
    Komenda P, Levin A. Analysis of cardiovascular disease and kidney outcomes in multidisciplinary chronic kidney disease clinics: complex disease requires complex care models. Curr Opin Nephrol Hypertens. 2006;15(1):61–6.CrossRefPubMedGoogle Scholar
  59. 59.
    Wright F, De Vito C, Langer B, Hunter A. Expert panel on multidisciplinary cancer conference standards. multidisciplinary cancer conferences: a systematic review and development of practice standards. Eur J Cancer. 2007;43(6):1002–10.CrossRefPubMedGoogle Scholar
  60. 60.
    Munro A, Swartzman S. What is a virtual multidisciplinary tea (vMDT)? Br J Cancer. 2013;108(12):2433–41.CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61. News Transcript. DoD News Briefing – Secretary Rumsfeld and Gen. Myers, United States Department of Defense ( 2012.

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  • Victoria Grandage
    • 1
    Email author
  • Susan Mehta
    • 1
  • Rachael Windsor
    • 1
  1. 1.University College London Hospitals NHS Foundation TrustLondonUK

Personalised recommendations